Media Contact
Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50
Shannon Iwaniuk
Director, Global Communications
shannon.iwaniuk@galderma.com
+1 720 308 1336
]]>
ZUG, Switzerland / CARLSBAD, CA, U.S., November 29, 2021 – Galderma, the world’s largest independent dermatology company, announced that it has signed a definitive agreement to acquire ALASTIN Skincare®, Inc. (“ALASTIN”), a specialty aesthetics company dedicated to developing innovative and clinically-tested physician-dispensed skincare products. The acquisition is subject to customary closing conditions and necessary regulatory approvals. Financial terms of the transaction have not been disclosed.
ALASTIN’s premium skincare portfolio is fully incremental to and synergistic with Galderma’s integrated dermatology platform. Founded in 2015, ALASTIN provides a comprehensive collection of cutting-edge, scientifically-proven products for daily skincare regimens and peri-procedural use. ALASTIN’s product offerings are backed by its patented TriHex Technology®, a proprietary blend of peptides and active botanicals to support the appearance of rejuvenated skin. Since inception, ALASTIN has delivered rapid and consistent sales growth, achieving a CAGR of 106% between 2016 and 2020, one of the highest of any professional skincare company. ALASTIN Skincare® was ranked the No. 1 preferred skincare brand in a blinded survey of physicians who carry ALASTIN and other skincare brands, conducted by Corsica Life Sciences in December 2020. The company was named as one of Forbes best start-up employers in America in 2020 and 2021 and was named as one of the fastest growing private companies in America on the INC 5000 2020 and 2021 lists.
"Galderma’s business consistently delivers strong results and remains at the forefront of this rapidly expanding market, driven by increasing consumer interest and acceptance of aesthetic procedures. The addition of ALASTIN, with its synergistic portfolio and expertise in science-proven skincare, increases our ability to serve the needs of consumers and underscores our commitment to be the partner of choice for aesthetic professionals. “This transaction will further enhance our premium product offering and provides a tremendous platform for future growth. We look forward to welcoming the ALASTIN team into Galderma and partnering with them to advance the science of dermatology together." Flemming Ørnskov, M.D., Mph Chief Executive Officer Galderma
By leveraging its global reach and integrated dermatology platform, Galderma will unlock ALASTIN’s next growth phase as it reaches more healthcare professionals and consumers more effectively. Galderma will also support further product innovation of ALASTIN’s portfolio, while simultaneously enabling cross-selling opportunities for ALASTIN’s products and technologies in the U.S. Combining Galderma’s world class pipeline and track record of first-to-market innovation with ALASTIN’s proprietary and award-winning skincare technology represents an unparalleled opportunity for Galderma to better meet the needs of aesthetic professionals and patients.
"We are thrilled to become part of Galderma for the next stage of ALASTIN’s growth story. We share the same vision of bringing the highest levels of science and innovation to the professional skincare market, and I look forward to working with the team to leverage Galderma’s expertise in this space to drive the ALASTIN Skincare® brand to new heights.” Diane S. Goostree President and CEO Alastin Skincare
Ropes & Gray LLP is acting as legal advisor to Galderma, and Latham & Watkins LLP is acting as legal advisor to ALASTIN. William Blair & Company, LLC is serving as the exclusive financial advisor to ALASTIN.
About Galderma
Galderma is the world’s largest independent dermatology company, present in approximately 100 countries. Since our inception in 1981, we have been driven by a complete dedication to dermatology. We deliver an innovative, science-based portfolio of sophisticated brands and services across Aesthetics, Consumer Care and Prescription Medicine. Focused on the needs of consumers and patients, we work in partnership with healthcare professionals to ensure superior outcomes. Because we understand that the skin we’re in shapes our life stories, we are advancing dermatology for every skin story. For more information: www.galderma.com.
About ALASTIN
ALASTIN Skincare® is the fastest-growing physician-dispensed skincare brand, with innovative, scientifically-proven and clinically-tested products. Founded in 2015, ALASTIN Skincare, Inc. provides a comprehensive collection of cutting-edge products for daily skincare regimens and peri-procedural use. We strategically focus research and development on innovative products with the greatest potential impact for patients and providers. Our team’s mission is to bring the highest levels of pharmaceutical science and innovation to the physician-dispensed skincare industry while creating a new category of products designed to be synergistic with procedures.
Media Contact Galderma
Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50
Shannon Iwaniuk
Global Communications, US
shannon.iwaniuk@galderma.com
+1 720 308 1336
ALASTIN Media Contact
Holly Curtis
holly@blendedstrategy.com
1 Kline Group’s 2020 Professional Skincare: U.S. Market Analysis and Opportunities report
]]>
Now in its 27th year, the Deloitte Technology Fast 500™ provides a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies — both public and private — in North America. Technology Fast 500™ award winners are selected based on percentage fiscal year revenue growth from 2017 to 2020.
“Each year the Technology Fast 500 shines a light on leading innovators in technology and this year is no exception,” said Paul Silverglate, vice chair, Deloitte LLP and U.S. technology sector leader. “In the face of innumerable challenges resulting from the pandemic, the best and brightest were able to pivot, reinvent and transform and grow. We celebrate the winning organizations and especially the talented employees driving their success.”
"We are honored to be recognized by Deloitte as one of the fastest-growing companies in North America," said Diane S. Goostree, President and CEO of ALASTIN Skincare. "Our commitment to science-backed skincare innovations, our laser-sharp focus on the needs of our customers, as well as our talented team of employees have firmly established ALASTIN Skincare as a recognized leader in the professional skincare space. We look forward to continuing to provide innovative skincare products for both peri-procedure use and daily skincare."
]]>As a leading performer year over year, ALASTIN Skincare continues to offer innovative and clinically validated products within the professional skincare market. According to the Kline 2020 Professional Skincare Report, despite the challenges of 2020 due to the COVID-19 pandemic, the skincare market proved to be resilient and dynamic with sales continuing to grow. With consumers desiring to bring the in-office and spa experience to their homes during the pandemic, ALASTIN Skincare leaned in on social media, addressing topics such as the importance of daily skincare routines as well as procedure preparation and post-care, providing education and product recommendations to help consumers correct and prevent the signs of aging of the skin.
ALASTIN Skincare launched their newest post-procedure innovation in January 2020, with INhance Post-Injection Serum with TriHex Technology,® designed to help accelerate recovery from post-injection bruising and swelling. According to the Aesthetic Society’s 2019 Annual Report, more than $1.6 billion dollars were spent on injectables such as dermal fillers and toxins in the U.S. in 2019, reiterating the need and importance of ALASTIN’s latest product innovation for both physicians and consumers in the aesthetic market.
“We are so excited to be recognized as the fastest-growing brand in the professional skincare market again this year,” said Diane S. Goostree, President and CEO of ALASTIN Skincare. “Despite the challenging environment of 2020, our continued commitment to breakthrough science and aesthetic phyisicians has solidified ALASTIN’s position as an innovative leader in the professional skincare space and allowed us to maintain our leading growth position. As we continue on our path of rapid growth, we look forward to providing new and innovative peri-procedure and daily skincare products for our customers.”
Visit alastin.com for more information or to find a list of physicians who offer Alastin.
]]>
Ms. Edwards holds a proven track record of successful business leadership and global development of leading brands in the medical aesthetics arena. Ms. Edwards most recently served as President of North America for Sinclair Pharma. Prior to Sinclair, she was at Allergan, Inc. where she was the Vice President of International Strategic Marketing, Medical Aesthetics Franchise, in the UK. She also has experience with Allergan in the US, in both aesthetic and therapeutic areas. Ms. Edwards began her career in Sales and Marketing roles at Pfizer.
“We are extremely pleased to have Amber Edwards join ALASTIN as a key member of the executive team to lead our US and International commercialization activities as we continue the rapid growth of our company”, said Diane S. Goostree, President and CEO of ALASTIN Skincare. “Amber’s strategic perspectives and global experience will be extremely helpful as we leverage our innovative science and products and expand our footprint in the aesthetic marketplace.”
Ms. Edwards stated, “I am thrilled to join an organization that has made such a notable mark in a crowded segment, and at a time they are experiencing tremendous opportunity and momentum. ALASTIN has demonstrated a commitment to science and ultimately to patients, identifying an innovative approach to helping physicians maximize patient results. I believe they have only scratched the surface and am honored to lead the commercial path forward.”
]]>“The dermal filler segment is one of the largest segments of the Aesthetic market with continued growth projected for many years to come. ALASTIN remains at the forefront of the professional skincare market as the fastest growing skincare company in this space, offering novel peri-procedure formulations which improve the patient experience,” says Jim Hartman, Chief Commercial Officer of ALASTIN Skincare.
Dr. Melanie Palm, Art of Skin MD, states, “As a board-certified dermatologist, I want an effective, easy to use, and well-tolerated product to hasten resolution of bruising and swelling. I had the distinct privilege to have the opportunity to evaluate INhance Post-Injection Serum as one of the early clinical investigators and it delivers on all of these fronts. It is likely to become my standard of care for topical application immediately following cosmetic procedures.”
This clinically tested formula features a combination of advanced technologies including patented TriHex Technology® that supports the skin’s ability to clear out damaged elastin and collagen and produce new, healthy elastin and collagen; ChromaFADE Technology™ to accelerate post-injection recovery by supporting the removal of broken down red blood cells responsible for creating bruising discoloration and swelling; and other key active ingredients that support hyaluronic acid production and skin plumping.
“ALASTIN INhance Post-Injection Serum is the solution for our patients desiring to minimize their downtime after injectables. The combination of scientifically validated TriHex Technology along with rapid reduction of bruising and swelling make this the perfect post treatment product. It takes the injectable practice to the next level and provides the best in post care technology,” stated Dr. Carolyn Jacob, Chicago Cosmetic Surgery and Dermatology.
In a clinical study*, 81% of patients experienced less bruising after their treatment at day 2 and 3 on the INhance Post-Injection Serum treated side vs. the side treated with a comparator, resulting in less patient downtime and greater symptomatic relief. Additionally, in a patient survey, 100% of patients stated they would prefer a topical serum for post injection bruising and swelling vs. an arnica patch.
* Data on file, Alastin Skincare, Inc. 2020
Visit www.alastin.com to find a physician retailer near you.
]]>CARLSBAD, CA - March 11, 2019 — ALASTIN Skincare®, Inc., a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products with patented TriHex Technology®, is thrilled to announce that the TransFORM Body Treatment has been awarded a 2019 NewBeauty Award in the innovations category.
NewBeauty acknowledges the best products, treatments and trends in cosmetics and aesthetics with their innovation category described as “the future is now: these no-frills releases do what was previously only a dream.” TransFORM Body Treatment was chosen among a competitive landscape of leading aesthetic companies and is the only cosmeceutical skincare product selected in the innovation category.
The one-of-a-kind TransFORM Body Treatment with TriHex Technology® is a revolutionary topical body treatment that works in tandem with non-surgical body fat reduction and energy-based body skin tightening procedures to complement and optimize results. When applied post-treatment, it helps to accelerate outcomes by supporting the body’s natural repair processes while also supporting the production of elastin and collagen to enhance procedure results. Additionally, it can be used as a stand-alone skin tightening treatment to address lax, crepey skin texture associated with aging.
“Patients are always asking what they can do to enhance the results from non-invasive body sculpting or volume reducing procedures, says Dr. Amy B. Lewis, Cosmetic Dermatologist in New York City. “ALASTIN Skincare found a solution to a need previously unmet with TransFORM Body Treatment, which has become an important part of the body sculpting protocol in my office. TransFORM aids in clearing residual broken-down fat debris in the treated area and also helps recondition crepey loose skin by supporting new collagen and elastin production. Patients continue to use it long term to maintain improved skin texture.”
TransFORM Body Treatment with TriHex Technology retails for $195 and can be purchased from ALASTIN Skincare® aesthetic physicians’ offices. Visit alastin.com for more information and to find a physician retailer near you.
]]>CARLSBAD, CA — January 22, 2018 — ALASTIN Skincare®,Inc. - a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products, has incorporated its proven, proprietary TriHex Technology® into a revolutionary new product designed for the specific needs of the neck and décolletage: Restorative Neck Complex with TriHex Technology®.
This breakthrough treatment is formulated to address the unique challenges of the area below the chin and above the chest such as crepey skin, skin laxity, and photo-aged discoloration that may accumulate over time. The TriHex Technology® in ALASTIN's new Restorative Neck Complex helps correct these signs of aging, resulting in a firmer, more elastic, and smoother appearance of the neck and décolletage and a more even skin tone.
ALASTIN Skincare is a leader in the aesthetic space in developing products which are designed to enhance skin health and reawaken the skin's natural ability to repair and rejuvenate itself. TriHex Technology® supports the production of new elastin and collagen and helps rebuild and recycle the skin's extracellular matrix (ECM) by clearing out byproducts of aging from exposure to sun and pollution. This, in turn, promotes the skin's capacity to generate fresh, new skin that is strong and supple.
"The delicate neck and décolletage area is more prone to redness, wrinkling, dryness and loss of elasticity compared to the face," says Texas Dermatologist Suneel Chilukuri, MD, from Refresh Dermatology. "In my cosmetic dermatology practice, I have patients presenting with concerns of a "sagging" neck on a daily basis. Based on my experience with this product, Alastin's Restorative Neck Complex is both an excellent topical treatment when used on its own as a part of an ongoing skin care routine, and is also appropriate to pair with a variety of neck and chest rejuvenating procedures to provide additive benefits."
All ALASTIN products are fragrance-free, paraben-free, and cruelty-free. ALASTIN Restorative Neck Complex retails for $110 and can be purchased from ALASTIN Skincare® aesthetic physicians' offices. Visit www.alastin.com to find a physician retailer near you.
]]>"Dr. Widgerow brings a wealth of basic science research, clinical experience and skincare product development expertise to Alastin during an exciting time in our company's growth," said Diane Goostree, President and CEO of Alastin. "The recruitment of clinical leadership represents another important step in the evolution of Alastin Skincare. With Dr. Widgerow's broad international experience leading research development programs in a variety of medical device innovations and wound care arenas, we are well positioned to continue advancing our proprietary formulations to patients through unique product offerings."
Dr. Widgerow completed his undergraduate and post-graduate studies at the University of the Witwatersrand, South Africa. He has held various positions in numerous academic and professional associations including that of President of the Association of Plastic and Reconstructive surgery of Southern Africa (APRSSA). He is a Fellow of the American College of Surgeons and was appointed Honorary Professor by the Senate of Wits University in 1999. He is author of over 130 plastic surgical related publications and 2 books.
After 20 years in private plastic surgical practice in South Africa, Prof Widgerow relocated to Irvine California in Dec 2009 to pursue his interests in research, medical device innovations and wound care, but he still plays an active role in academic medicine world-wide. In August 2012 he joined the University of California Irvine Plastic Surgery Division as Adjunct Full Professor and Director of the Center for Tissue Engineering (CTE). He has redesigned and introduced major Research projects to the CTE Lab and is involved in collaborative efforts with major Institutions seeking to further translational science. He has recruited a team of 20 researchers and runs a vibrant, dynamic research facility at UCIMC.
]]>
“Many products promote collagen generation, but perfect, “baby-like” skin recovery needs both collagen and elastin. Alastin’s TriHex Technology™ is a proprietary blend of peptides that signals to the body to activate the production of elastin and collagen, reinforcing the skin’s natural regenerating properties,” said Scott Glenn, CEO of Alastin Skincare. “We are very excited about introducing a new technology into the marketplace, and our products will be distributed exclusively through our physician partners.”
]]>